2,2,2-Trifluoro-1-(1H-indol-5-yl)ethanone, 1g

(S)-2-Morpholinopropanoic acid, 98%, 250mg

2-(2,5-Dibromothiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

N-Octylphosphonic acid, 95.0%, 5g

5-Bromo-2-(pyrrolidin-3-yloxy)pyrimidine, 95.0%, 100mg

2-Iodo-4-nitroanisole, 98.0%, 100g

(2R)-2-amino-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid, 97%, 5g

2,2'-(3-Methylthiophene-2,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 96%, 5g

Panaxadiol>95.0%(GC)250mg

HEXANAL 2,4-DINITROPHENYLHYDRAZONE, 95%, 1g

(E)-3-(Pyridazin-4-yl)acrylic acid, 98%, 1g

Methyl 6-Amino-5-bromonicotinate, 97.0%, 1g

1,3-Bis(4-aminophenyl)thiourea, 100mg